Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1996 1
1997 1
2004 1
2006 1
2008 1
2016 1
2017 1
2018 1
2019 1
2020 1
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction.
Fanni S, Scheggi S, Rossi F, Tronci E, Traccis F, Stancampiano R, De Montis MG, Devoto P, Gambarana C, Bortolato M, Frau R, Carta M. Fanni S, et al. Neurobiol Dis. 2019 Jan;121:120-130. doi: 10.1016/j.nbd.2018.09.018. Epub 2018 Sep 24. Neurobiol Dis. 2019. PMID: 30261284
Although 1-3,4-dihydroxyphenylalanine (L-DOPA) is the mainstay therapy for treating Parkinson's disease (PD), its long-term administration is accompanied by the development of motor complications, particularly L-DOPA induced dyskinesia (LID), that dramatically affec …
Although 1-3,4-dihydroxyphenylalanine (L-DOPA) is the mainstay therapy for treating Parkinson's disease (PD), its long-term administr …
Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical).
Cadegiani FA, McCoy J, Gustavo Wambier C, Goren A. Cadegiani FA, et al. Cureus. 2021 Feb 1;13(2):e13047. doi: 10.7759/cureus.13047. Cureus. 2021. PMID: 33643746 Free PMC article.
Compared to the placebo group, on Day seven, subjects taking dutasteride had a higher virologic remission rate (64.3% versus 11.8%; p=.0094), higher clinical recovery rate (84.7% versus 57.5%; p=.03), higher mean [standard deviation: SD] oxygen saturation (97.0% [1.4%] versus 95. …
Compared to the placebo group, on Day seven, subjects taking dutasteride had a higher virologic remission rate (64.3% versus 11.8%; p=.0094) …
A Comprehensive Overview of the Past, Current, and Future Randomized Controlled Trials in Hepatic Encephalopathy.
Ilie OD, Duta R, Nita IB, Dobrin I, Gurzu IL, Girleanu I, Huiban L, Muzica C, Ciobica A, Popescu R, Cianga P, Stanciu C, Cimpoesu D, Trifan A. Ilie OD, et al. Medicina (Kaunas). 2023 Dec 10;59(12):2143. doi: 10.3390/medicina59122143. Medicina (Kaunas). 2023. PMID: 38138246 Free PMC article. Review.
Despite recent interest in this condition, the effectiveness of secondary prophylaxis involving rixafimin, lactulose, or L-ornithine L-aspartate (LOLA) may be hindered by the unique microbial profiles each patient possesses. ...
Despite recent interest in this condition, the effectiveness of secondary prophylaxis involving rixafimin, lactulose, or L-ornithine …
Partition kinetics of chlorobenzenes in a sediment-water system.
Djohan D, Yu J, Connell D. Djohan D, et al. Chemosphere. 2017 Nov;186:938-947. doi: 10.1016/j.chemosphere.2017.08.060. Epub 2017 Aug 12. Chemosphere. 2017. PMID: 28838040
A partition kinetics model was developed to determine kinetics rate constants. Adsorption rate constants increased (DCB 15.3; HCB 26.3 L kg(-1) h(-1)) while desorption rate constants decreased (DCB 0.41; HCB 0.01 h(-1)) with K(OW) values. ...
A partition kinetics model was developed to determine kinetics rate constants. Adsorption rate constants increased (DCB 15.3; HCB 26.3 L
Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report.
Pinzon RT, Haryono FK, Darmawan NE, Salikim MAM, Veronica V. Pinzon RT, et al. BMC Neurol. 2022 Aug 26;22(1):322. doi: 10.1186/s12883-022-02834-8. BMC Neurol. 2022. PMID: 36028809 Free PMC article.
An increase of neutrophil-to-lymphocyte ratio (16.9) and C-reactive protein level (31.75 mg/L) indicates ongoing inflammation. Head CT scan shows no abnormalities. ...
An increase of neutrophil-to-lymphocyte ratio (16.9) and C-reactive protein level (31.75 mg/L) indicates ongoing inflammation. Head C …
Assessing Anti-Social and Aggressive Behavior in a Zebrafish (Danio rerio) Model of Parkinson's Disease Chronically Exposed to Rotenone.
Ilie OD, Duta R, Jijie R, Nita IB, Nicoara M, Faggio C, Dobrin R, Mavroudis I, Ciobica A, Doroftei B. Ilie OD, et al. Brain Sci. 2022 Jul 8;12(7):898. doi: 10.3390/brainsci12070898. Brain Sci. 2022. PMID: 35884705 Free PMC article.
Material and Methods: Thus, we exposed zebrafish to ROT-2.5 g/L, valproic acid (VPA)-0.5 mg/mL, anti-parkinsonian drugs (LEV/CARB)-250 mg + 25 mg, and probiotics (PROBIO)-3 g for 32 days by assessing the anti-social profile and mirror tests and counterclockwise rotation ev …
Material and Methods: Thus, we exposed zebrafish to ROT-2.5 g/L, valproic acid (VPA)-0.5 mg/mL, anti-parkinsonian drugs (LEV/CARB)-25 …
Effect of process parameters on production of a biopolymer by Rhizobium sp.
Duta FP, De França FP, Sérvulo EF, De Almeida Lopes LM, Da Costa AC, Barros A. Duta FP, et al. Appl Biochem Biotechnol. 2004 Spring;113-116:639-52. doi: 10.1385/abab:114:1-3:639. Appl Biochem Biotechnol. 2004. PMID: 15054283
The experimental design showed that a low substrate concentration (10.0 g/L), and low aeration (0.2 vvm) and agitation (200 rpm) levels should be used. ...
The experimental design showed that a low substrate concentration (10.0 g/L), and low aeration (0.2 vvm) and agitation (200 rpm) leve …
The effect of exercise on bleeding time and local production of prostacyclin and thromboxane.
Carter JW, Ready AE, Singhroy S, Duta E, Gerrard JM. Carter JW, et al. Eur J Appl Physiol Occup Physiol. 1989;59(5):355-9. doi: 10.1007/BF02389810. Eur J Appl Physiol Occup Physiol. 1989. PMID: 2513183
There was similarly an increase in thromboxane B2 production from 6.40 nmol.l-1 before to 11.50 nmol.l-1. Most subjects also showed an increase in the length of the bleeding time and in the production of bleeding time 6-keto-PGF1 alpha. ...
There was similarly an increase in thromboxane B2 production from 6.40 nmol.l-1 before to 11.50 nmol.l-1. Most subjects also s …
15 results